AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
OKYO Pharma Limited Ordinary Shares
XNAS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG015TS36P0
1.40▼ 0.07 (-4.76%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.47
Day's Range
1.40 – 1.47
52-Week Range
1.26 – 3.20
Volume
13.8K
Avg Volume
64.7K
Share Statistics
Shares Outstanding
Employees
4
Exchange
XNAS
Listed
2022-05-17
Share count as of July 15, 2026

OKYO Pharma Limited Ordinary Shares (OKYO) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about OKYO Pharma Limited Ordinary Shares (OKYO)
What is OKYO Pharma Limited Ordinary Shares's Market Cap?
OKYO Pharma Limited Ordinary Shares's Market Cap is $73.5M, based on as-reported figures from SEC (XBRL) filings.
What is OKYO Pharma Limited Ordinary Shares's Net Income (TTM)?
OKYO Pharma Limited Ordinary Shares's Net Income (TTM) is -$8.9M, based on as-reported figures from SEC (XBRL) filings.
What is OKYO Pharma Limited Ordinary Shares's Diluted EPS (TTM)?
OKYO Pharma Limited Ordinary Shares's Diluted EPS (TTM) is -0.17, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · OKYOAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Mar 31, 2025Mar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020
Operating expenses:
Research and development
Operating Expenses
Total operating expenses
Other income/(expense):
Income Before Tax
Loss from operations before income taxes
Income tax
Loss for the year
Other Comprehensive loss:
Foreign Currency Translation Adjustments
Comprehensive loss
Earnings Per Share (Basic)
Earnings Per Share (Diluted)